Skip to main content
News Icon

Important visit from Melbourne

A high-profile delegation of the University of Melbourne visited the University of Bonn in order to discuss a closer cooperation in research and training of early-career researchers. The Australian university is one of three strategic partnerships the University of Bonn maintains. Close links already exist especially in the areas of Food and Nutrition Sciences and Agricultural Sciences.

The Australian delegation of five was led by Vice-Chancellor Prof. Duncan Maskell. The position of Vice-Chancellor is equivalent to the position of a Rector in the German higher education system. Prof. Dr. Andreas Zimmer, Vice Rector for Research and Innovation, and Prof. Dr. Klaus Sandmann, Vice Rector for University Development and Equal Opportunity provided a warm welcome to the honorable guest. Rector Prof Dr Dr hc Michael Hoch met the Vice-Chancellor the following day at the reception of the University of Melbourne at the Australian Embassy in Berlin.

The Cluster of Excellence ImmunoSensation and the University of Melbourne have been working together closely since 2016: Under the name ”Bonn & Melbourne Research and Graduate School‟, the two partners launched an International Research Training Group with by now over 30 jointly mentored doctorates. The exchange of doctoral students, young academics and researchers is promoted by the ”Bonn & Melbourne Academy for Excellence in ImmunoSciences/Infection‟ (BM-AXIS).

Find the press release here.

Related news

PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry
News Ludwig

News categories: Publication

New findings on infection with the Epstein-Barr virus

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Bonn researchers have now identified genetic and non-genetic factors that help the body fight EBV. To do this, they evaluated genome sequencing data, which is actually intended for characterizing the human genome, in a new way. Using the new technique, they were able to estimate the amount of EBV in the blood and find correlations in large health data sets. Their findings have now been published in the renowned journal Nature.
View entry
News Icon

News categories: Publication

New insights into the human immune defense against poxviruses

An international research team involving Bonn scientist has made an important contribution to understanding the human immune response to poxviruses: The scientists were able to show for the first time that different human cell types recognize poxviruses via different sensors in order to trigger inflammatory responses. At the same time, the team developed the world's first nanobodies that can specifically block the DNA sensor AIM2 – a tool that opens up new possibilities for inflammation and infection research. The paper has now been published in The EMBO Journal.
View entry

Back to the news overview